Andreas Halvorsen's EW Position Overview
Andreas Halvorsen (via Viking Global Investors Lp) currently holds 1.1 M shares of Edwards Lifesciences Corporation (EW) worth $87.89 M, representing 0.25% of the portfolio. First purchased in 2019-Q3, this short-term holding has been held for 6 quarters.
Based on 13F filings, Andreas Halvorsen has maintained this position in EW for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 3.07 M shares. Largest reduction occurred in Q4 2025, reducing 3.07 M shares.
Analysis based on 13F filings available since 2013 Q2
Andreas Halvorsen's Edwards Lifesciences Corporation (EW) Holding Value Over Time
Track share changes against reported price movement
Quarterly Edwards Lifesciences Corporation (EW) Trades by Andreas Halvorsen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1.1 M | New Buy | 1.1 M | $80.08 |
| Q4 2025 | -3.07 M | Sold Out | 0 | $0.00 |
| Q3 2025 | +3.07 M | New Buy | 3.07 M | $77.77 |
| Q1 2020 | -475,719 | Sold Out | 0 | $0.00 |
| Q4 2019 | -136,725 | Reduce 22.32% | 475,719 | $77.76 |
| Q3 2019 | +612,444 | New Buy | 612,444 | $73.30 |
Andreas Halvorsen's Edwards Lifesciences Corporation Investment FAQs
Andreas Halvorsen first purchased Edwards Lifesciences Corporation (EW) in Q3 2019, acquiring 612,444 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen has held Edwards Lifesciences Corporation (EW) for 6 quarters since Q3 2019.
Andreas Halvorsen's largest addition to Edwards Lifesciences Corporation (EW) was in Q3 2025, adding 3,069,151 shares worth $238.69 M.
According to the latest 13F filing for Q1 2026, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 1,097,578 shares of Edwards Lifesciences Corporation (EW), valued at approximately $87.89 M.
As of the Q1 2026 filing, Edwards Lifesciences Corporation (EW) represents approximately 0.25% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings.
Andreas Halvorsen's peak holding in Edwards Lifesciences Corporation (EW) was 3,069,151 shares, as reported at the end of Q3 2025.